AZN logo

AstraZeneca (AZN) Inventory

Annual Inventory

$5.29 B
-$136.00 M-2.51%

December 1, 2024

Summary

Performance

1-Year Change

-2.51%

3-Year Change

-41.13%

5-Year Change

+65.61%

15-Year Change

+74.23%

AZN Inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.85%
AZN annual inventory is higher than 97.85% of companies in Healthcare sector

High & Low

All-time High

$8.98 B
AZN annual inventory is currently -41.13% below its historical high of $8.98 billion

3-Year Low

$4.70 B
AZN annual inventory is currently +12.53% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
AZN previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
AZN next annual earnings announcement has not yet been scheduled

OtherAZNbalance sheetmetrics:

Annual Total Assets

$104.03 B
AZN annual total assets is $104.03 billion

Annual Current Assets

$25.83 B
AZN annual total current assets is $25.83 billion

Annual Total Liabilities

$63.16 B
AZN annual total liabilities is $63.16 billion

Annual Current Liabilities

$27.87 B
AZN annual total current liabilities is $27.87 billion

Quarterly Inventory

$5.66 B
-$5.00 M-0.09%

September 30, 2024

Summary

Performance

3-Month Change

-0.09%

1-Year Change

+6.99%

3-Year Change

-8.97%

5-Year Change

-8.97%

AZN Quarterly Inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.83%
AZN quarterly inventory is higher than 97.83% of companies in Healthcare sector

High & Low

All-time High

$11.53 B
AZN quarterly inventory is currently -50.90% below its historical high of $11.53 billion

3-Year Low

$4.70 B
AZN quarterly inventory is currently +20.49% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
AZN next earnings announcement has not yet been scheduled

OtherAZNbalance sheetmetrics:

Quarterly Total Assets

$104.92 B
AZN quarterly total assets is $104.92 billion

Quarterly Current Assets

$24.16 B
AZN quarterly total current assets is $24.16 billion

Quarterly Total Liabilities

$64.12 B
AZN quarterly total liabilities is $64.12 billion

Quarterly Current Liabilities

$25.93 B
AZN quarterly total current liabilities is $25.93 billion

Inventory Formula

Inventory = Beginning Inventory + Purchases − Cost of Goods Sold

Annual Inventory

$5.29 B
AZN annual inventory is $5.29 billion

Annual Cost Of Goods Sold

$10.21 B
AZN annual cost of goods sold is $10.21 billion

AZN Inventory Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.5%+7.0%
3 y3 years-41.1%-9.0%
5 y5 years+65.6%-9.0%

AZN Inventory Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-41.1%+12.5%-37.0%+20.5%
5 y5-year-41.1%+65.6%-46.2%+81.3%
alltimeall time-41.1%+360.7%-50.9%-100.0%

AstraZeneca Inventory History

DateAnnualQuarterly
Dec 2024
$5.29 B(-2.5%)
-
Sep 2024
-
$5.66 B(-0.1%)
Jun 2024
-
$5.67 B(+6.2%)
Mar 2024
-
$5.34 B(-1.6%)
Dec 2023
$5.42 B(+15.4%)
$5.42 B(+2.5%)
Sep 2023
-
$5.29 B(+4.8%)
Jun 2023
-
$5.05 B(+1.7%)
Mar 2023
-
$4.97 B(+5.7%)
Dec 2022
$4.70 B(-47.7%)
$4.70 B(-7.5%)
Sep 2022
-
$5.08 B(-18.4%)
Jun 2022
-
$6.22 B(-18.4%)
Mar 2022
-
$7.62 B(-15.1%)
Dec 2021
$8.98 B(+123.2%)
$8.98 B(-14.7%)
Sep 2021
-
$10.53 B(+121.1%)
Jun 2021
-
$4.76 B(+11.3%)
Mar 2021
-
$4.28 B(+6.3%)
Dec 2020
$4.02 B(+26.0%)
$4.02 B(+9.3%)
Sep 2020
-
$3.68 B(+3.4%)
Jun 2020
-
$3.56 B(+14.1%)
Mar 2020
-
$3.12 B(-2.2%)
Dec 2019
$3.19 B(+10.5%)
$3.19 B(+2.0%)
Sep 2019
-
$3.13 B(-2.1%)
Jun 2019
-
$3.20 B(+4.8%)
Mar 2019
-
$3.05 B(+5.5%)
Dec 2018
$2.89 B(-4.8%)
$2.89 B(-4.5%)
Sep 2018
-
$3.03 B(-2.9%)
Jun 2018
-
$3.12 B(-5.0%)
Mar 2018
-
$3.28 B(+8.2%)
Dec 2017
$3.04 B(+30.0%)
$3.04 B(-4.0%)
Sep 2017
-
$3.16 B(+9.0%)
Jun 2017
-
$2.90 B(+9.4%)
Mar 2017
-
$2.65 B(+13.6%)
Dec 2016
$2.33 B(+8.9%)
$2.33 B(-3.6%)
Sep 2016
-
$2.42 B(-0.1%)
Jun 2016
-
$2.42 B(+3.3%)
Mar 2016
-
$2.34 B(+9.4%)
Dec 2015
$2.14 B(+9.3%)
$2.14 B(-2.3%)
Sep 2015
-
$2.19 B(-0.2%)
Jun 2015
-
$2.20 B(+11.7%)
Mar 2015
-
$1.97 B(+0.4%)
Dec 2014
$1.96 B(+2.7%)
$1.96 B(+0.2%)
Sep 2014
-
$1.96 B(-13.0%)
Jun 2014
-
$2.25 B(+4.0%)
Mar 2014
-
$2.16 B(+13.3%)
Dec 2013
$1.91 B(-7.4%)
$1.91 B(-8.0%)
Sep 2013
-
$2.08 B(-0.7%)
Jun 2013
-
$2.09 B(+2.5%)
Mar 2013
-
$2.04 B(-1.1%)
Dec 2012
$2.06 B(+11.3%)
$2.06 B(-1.4%)
Sep 2012
-
$2.09 B(+2.5%)
Jun 2012
-
$2.04 B(-0.0%)
Mar 2012
-
$2.04 B(+10.2%)
Dec 2011
$1.85 B(+10.1%)
$1.85 B(-5.3%)
Sep 2011
-
$1.96 B(-3.3%)
Jun 2011
-
$2.02 B(+6.5%)
Mar 2011
-
$1.90 B(+12.8%)
DateAnnualQuarterly
Dec 2010
$1.68 B(-3.9%)
$1.68 B(-7.1%)
Sep 2010
-
$1.81 B(+7.2%)
Jun 2010
-
$1.69 B(-5.1%)
Mar 2010
-
$1.78 B(+1.7%)
Dec 2009
$1.75 B(+7.0%)
$1.75 B(-7.8%)
Sep 2009
-
$1.90 B(+1.7%)
Jun 2009
-
$1.87 B(+9.6%)
Mar 2009
-
$1.70 B(+4.0%)
Dec 2008
$1.64 B(-22.8%)
$1.64 B(-21.5%)
Sep 2008
-
$2.08 B(-8.2%)
Jun 2008
-
$2.27 B(+4.6%)
Mar 2008
-
$2.17 B(+2.4%)
Dec 2007
$2.12 B(-5.8%)
$2.12 B(-17.2%)
Sep 2007
-
$2.56 B(-0.2%)
Jun 2007
-
$2.56 B(+11.7%)
Mar 2007
-
$2.29 B(+2.0%)
Dec 2006
$2.25 B(+2.0%)
$2.25 B(+1.9%)
Sep 2006
-
$2.21 B(-0.1%)
Jun 2006
-
$2.21 B(-1.7%)
Mar 2006
-
$2.25 B(+2.0%)
Dec 2005
$2.21 B(-27.0%)
$2.21 B(-11.5%)
Sep 2005
-
$2.49 B(-6.4%)
Jun 2005
-
$2.66 B(+20.7%)
Mar 2005
-
$2.21 B(-27.0%)
Dec 2004
$3.02 B(-0.1%)
$3.02 B(-1.9%)
Sep 2004
-
$3.08 B(-1.8%)
Jun 2004
-
$3.14 B(+1.3%)
Mar 2004
-
$3.10 B(+2.5%)
Dec 2003
$3.02 B(+16.5%)
$3.02 B(>+9900.0%)
Sep 2003
-
$0.00(-100.0%)
Jun 2003
-
$2.77 B(>+9900.0%)
Mar 2003
-
$0.00(-100.0%)
Dec 2002
$2.59 B(+8.0%)
$2.59 B(-77.5%)
Sep 2002
-
$11.53 B(+366.1%)
Jun 2002
-
$2.47 B(>+9900.0%)
Mar 2002
-
$0.00(-100.0%)
Dec 2001
$2.40 B(+14.1%)
$2.40 B(-78.5%)
Sep 2001
-
$11.16 B(+437.0%)
Jun 2001
-
$2.08 B(>+9900.0%)
Mar 2001
-
$0.00(-100.0%)
Dec 2000
$2.11 B(-2.3%)
$2.11 B(-81.1%)
Sep 2000
-
$11.15 B(+370.2%)
Jun 2000
-
$2.37 B(>+9900.0%)
Mar 2000
-
$0.00(-100.0%)
Dec 1999
$2.16 B(+6.3%)
$2.16 B(+8.2%)
Sep 1999
-
$1.99 B(+4.6%)
Jun 1999
-
$1.91 B(-6.1%)
Dec 1998
$2.03 B(+68.6%)
$2.03 B(+68.6%)
Dec 1997
$1.20 B(+3.2%)
$1.20 B(+3.2%)
Dec 1996
$1.17 B(-11.3%)
$1.17 B(-11.3%)
Dec 1995
$1.31 B(+8.4%)
$1.31 B(+1.3%)
Jun 1995
-
$1.30 B(+7.0%)
Dec 1994
$1.21 B(+5.7%)
$1.21 B(+5.7%)
Dec 1993
$1.15 B(-9.5%)
$1.15 B
Dec 1992
$1.27 B(-2.2%)
-
Dec 1991
$1.30 B(-0.3%)
-
Dec 1990
$1.30 B
-

FAQ

  • What is AstraZeneca annual inventory?
  • What is the all time high annual inventory for AstraZeneca?
  • What is AstraZeneca annual inventory year-on-year change?
  • What is AstraZeneca quarterly inventory?
  • What is the all time high quarterly inventory for AstraZeneca?
  • What is AstraZeneca quarterly inventory year-on-year change?

What is AstraZeneca annual inventory?

The current annual inventory of AZN is $5.29 B

What is the all time high annual inventory for AstraZeneca?

AstraZeneca all-time high annual inventory is $8.98 B

What is AstraZeneca annual inventory year-on-year change?

Over the past year, AZN annual inventory has changed by -$136.00 M (-2.51%)

What is AstraZeneca quarterly inventory?

The current quarterly inventory of AZN is $5.66 B

What is the all time high quarterly inventory for AstraZeneca?

AstraZeneca all-time high quarterly inventory is $11.53 B

What is AstraZeneca quarterly inventory year-on-year change?

Over the past year, AZN quarterly inventory has changed by +$370.00 M (+6.99%)